Bendig, S., Hartmann, A. M., Wessels, W., Beder, T., Kim, R., Passet, M., Gao, Q., Wolgast, N., Horns, J. M., Santos, L. A., Iben, K., Steffen, F. D., Cantoni, L., Kehden, B., Chitadze, G., Künstner, A., Busch, H., Bornhauser, B., Bourquin, J., Leguay, T. T., Boissel, N., Gökbuget, N., Iacobucci, I., Mullighan, C. G., Clappier, E., Baldus, C. D., Brüggemann, M., Bastian, L. (2026). IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response. Blood. https://doi.org/10.1182/blood.2025031102